Table 2.
Patients with coagulopathies and other hematological diseases.
| Total | Platelets (<20,000) | Platelets (20,000–50,000) | Platelets (>50,000) | NPS (n, %) | OPS (n, %) | Saliva (n, %) | |
|---|---|---|---|---|---|---|---|
| Coagulopathies 1 (n) | 97 | 14 | 7 | 71 | 10 (10.3) | 10 (10.3) | 9 (9.3) |
| Hemophilia A | 36 | 0 | 0 | 35 | 25 (69.4) | 24 (66.6) | 24 (66.6) |
| Hemophilia B | 9 | 0 | 0 | 7 | 4 (44.4) | 6 (66.6) | 6 (66.6) |
| Von Willwbrand disease | 1 | 0 | 0 | 1 | 1 (100) | 1 (100) | 1 (100) |
| Essential thrombocytopenia | 11 | 0 | 1 | 10 | 11 (100) | 11 (100) | 8 (72.7) |
| Thrombocytopenia purple | 32 | 14 | 6 | 9 | 31 (96.8) | 30 (93.7) | 29 (90.6) |
| Factor VII deficiency | 1 | 0 | 0 | 1 | 1 (100) | 1 (100) | 1 (100) |
| Hemoglobinopathy | 2 | 0 | 0 | 2 | 2 (100) | 2 (100) | 2(100) |
| Hereditary thrombopathy | 3 | 0 | 0 | 3 | 3 (100) | 3 (100) | 3 (100) |
| Paroxysmal Hemoglobinuria | 1 | 0 | 0 | 1 | 1 (100) | 1 (100) | 1 (100) |
| Paroxysmal Myoglobinuria | 1 | 0 | 0 | 1 | 1 (100) | 1 (100) | 1 (100) |
| Glanzan Disease | 1 | 0 | 0 | 1 | 1 (100) | 1(100) | 1 (100) |
| Other hematological diseases 2 | 943 | 2 | 6 | 935 | 90 (9.5) | 70 (7.4) | 65 (6.9) |
1 Two coagulopathy patients without platelets information; 2 216 patients with hematological diseases without platelets information.